TL;DR
A good model was built to help predict the prognosis of CC patients and provide a reference for personalized treatment and medication for different patients and according to the immunophenoscore and TIDE scores, the low-risk group tended to respond more to immunotherapy.
AI-generated by Semantic Scholar
Authors
Min Wang, Zhizun Li
